Cholecalciferol administration blunts the systemic renin–angiotensin system in essential hypertensives with hypovitaminosis D
Introduction: Vitamin D plasma levels are negatively associated with blood pressure and cardiovascular mortality, and vitamin D supplementation reduces cardiovascular events. Renin–angiotensin system (RAS) suppression may be one of the mechanisms involved. However, there are no interventional prospe...
Main Authors: | Davide Carrara, Matteo Bernini, Alessandra Bacca, Ilaria Rugani, Emiliano Duranti, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei, Giampaolo Bernini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2014-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320312471149 |
Similar Items
-
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II
by: Agostino Virdis, et al.
Published: (2011-01-01) -
ALGORITHMS FOR THE SUPPLEMENTATION OF CHOLECALCIFEROL IN THE TREATMENT AND PREVENTION OF HYPOVITAMINOSIS D IN ARTERIAL HYPERTENSION
by: Yakubova L. V., et al.
Published: (2019-09-01) -
Prevalence of hypovitaminosis D and the different-dose cholecalciferol supplementation effects on renal transplant recipients
by: Sergio Mazzola Poli de Figueiredo, et al.
Published: (2016-01-01) -
A randomized clinical trial of vitamin D3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D3
by: Jagrati Mathur, et al.
Published: (2017-08-01) -
Pharmacology of the Renin-Angiotensin system
by: Zerem Enver
Published: (2015-01-01)